Spelling suggestions: "subject:"allergy."" "subject:"ellergy.""
331 |
Activation of human eosinophils by novel t-helper type 2 cytokine IL-33: implications for the immunopathology of allergic inflammation.January 2009 (has links)
Chow, Yin Sau Joyce. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2009. / Includes bibliographical references (leaves 127-140). / Abstract also in Chinese. / Abstract --- p.I / 摘要 --- p.V / Acknowledgements --- p.VIII / Publications --- p.X / Table of contents --- p.XII / Abbreviations --- p.XV / Chapter Chapter 1: --- General Introduction --- p.1 / Chapter 1.1 --- Allergic diseases and allergic inflammation --- p.1 / Chapter 1.1.1 --- Allergic diseases and their prevalence --- p.1 / Chapter 1.1.2 --- Immunopathology of allergic inflammation --- p.2 / Chapter 1.2 --- Biology of human eosinophils --- p.4 / Chapter 1.2.1 --- Morphology --- p.4 / Chapter 1.2.2 --- Cell surface receptors and mediators --- p.4 / Chapter 1.2.3 --- Origin and development of eosinophils --- p.7 / Chapter 1.3 --- Eosinophils and allergic inflammation --- p.7 / Chapter 1.3.1 --- Adhesion molecules on eosinophils for emigration --- p.8 / Chapter 1.3.2 --- Eosinophil activation and inflammatory mediators --- p.13 / Chapter 1.3.3 --- Survival of eosinophils in allergic inflammation --- p.18 / Chapter 1.3.4 --- Immunopathological roles of eosinophils in allergic inflammation --- p.18 / Chapter 1.4 --- Intracellular signaling mechanisms --- p.20 / Chapter 1.4.1 --- Signal transduction pathways of eosinophils --- p.20 / Chapter 1.4.2 --- Inhibitors of signaling molecules --- p.26 / Chapter 1.5 --- Aim of study --- p.29 / Chapter Chapter 2: --- Materials and Methods --- p.31 / Chapter 2.1 --- Materials --- p.31 / Chapter 2.1.1 --- Human eosinophils --- p.31 / Chapter 2.1.2 --- Cell culture --- p.33 / Chapter 2.1.3 --- Cell surface and intracellular immunofluorescent staining --- p.36 / Chapter 2.1.4 --- Detection of cytokine and chemokine release --- p.39 / Chapter 2.1.5 --- Detection of cell viability and apoptosis --- p.40 / Chapter 2.1.6 --- Protein extraction --- p.40 / Chapter 2.1.7 --- Western blot analysis --- p.40 / Chapter 2.1.8 --- Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) --- p.42 / Chapter 2.2 --- Methods --- p.45 / Chapter 2.2.1 --- Purification of human eosinophils --- p.45 / Chapter 2.2.2 --- Cell culture --- p.46 / Chapter 2.2.3 --- Cell surface and intracellular immunofluorescent staining --- p.47 / Chapter 2.2.4 --- Detection of cytokine and chemokine release --- p.48 / Chapter 2.2.5 --- Detection of cell viability and apoptoas --- p.49 / Chapter 2.2.6 --- Protein extraction --- p.49 / Chapter 2.2.7 --- Western blot analysis --- p.50 / Chapter 2.2.8 --- SDS-PAGE --- p.50 / Chapter 2.2.9 --- Statistical analysis --- p.51 / Chapter Chapter 3: --- Role of Novel IL-1 Family Cytokine in Allergic Inflammation: IL-33-mediated Eosinophil Activation --- p.52 / Chapter 3.1 --- Introduction --- p.52 / Chapter 3.2 --- Results --- p.54 / Chapter 3.2.1 --- "Total protein expression of IL-33 receptor, ST2, of human eosinophils" --- p.54 / Chapter 3.2.2 --- "Intracellular protein expression of IL-33 receptor, ST2,in human eosinophils" --- p.55 / Chapter 3.2.3 --- "Extracellular protein expression of IL-33 receptor, ST2, on human eosinophils" --- p.56 / Chapter 3.2.4 --- "Effects of IL-1β IL-18, and IL-33 on survival of human eosinophils" --- p.57 / Chapter 3.2.5 --- "Effects of IL-1β, IL-18, and DL-33 on surface adhesion molecule expression on human eosinophils" --- p.60 / Chapter 3.2.6 --- "Effects of IL-1β, IL-18, and IL-33 on chemokine and cytokine release from human eosinophils" --- p.64 / Chapter 3.2.7 --- "Synergistic effects of IL-1β, IH8, and IL-33 on IL-6 release from human eosinophils" --- p.69 / Chapter 3.2.8 --- "Effects of transcription and translation inhibitors on IL- 1β, IL-18, and IL-33-induced chemokine and cytokine release from human eosinophils" --- p.71 / Chapter 3.2.9 --- "Effects of different inhibitors on lL-1β, IL-18, and IL-33-induced survival enhancement of human eosinophils" --- p.75 / Chapter 3.2.10 --- Effects of different inhibitors on IL-1β and IL-33-mediated surface expression of adhesion molecules on human eosinophils --- p.77 / Chapter 3.2.11 --- "Effects of different inhibitors on IL-33, IL-1β,and IL-18-induced release of CCL2,CXCL8,and IL-6 from human eosinophils" --- p.79 / Chapter 3.2.12 --- "Effects of IL-33, IL-1β and IL-18 on activation of ERK, p38 MAPK, and NF-kB pathways in human eosinophils" --- p.83 / Chapter 3.3 --- Discussion --- p.85 / Chapter Chapter 4: --- Co-culture of Eosinophils & Epidermal Keratinocytes Upon IL-33 Stimulation: Implications for Immunopathology of Atopic Dermatitis --- p.95 / Chapter 4.1 --- Introduction --- p.95 / Chapter 4.2 --- Results --- p.98 / Chapter 4.2.1 --- Effect of IL-33 on surface expression of CD18 and ICAM-1 upon the interaction of human eosinophils and epidermal keratinocytes --- p.98 / Chapter 4.2.2 --- Effect of IL-33 on CCL2 release upon the interaction of human eosinophils and epidermal keratinocytes --- p.98 / Chapter 4.2.3 --- Effect of IL-33 on CXCL8 release upon the interaction of human eosinophils and epidermal keratinocytes --- p.101 / Chapter 4.2.4 --- Effect of IL-33 on IL-6 release upon the interaction of human eosinophils and epidermal keratinocytes --- p.101 / Chapter 4.2.5 --- Source(s) of CCL2 in co-culture of human eosinophils and epidermal keratinocytes upon IL-33 stimulation --- p.104 / Chapter 4.2.6 --- Source(s) of CXCL8 in co-culture of human eosinophils and epidermal keratinocytes upon IL-33 stimulation --- p.105 / Chapter 4.2.7 --- Source(s) of IL-6 in co-culture of human eosinophils and epidermal keratinocytes upon BL-33 stimulation --- p.108 / Chapter 4.2.8 --- "Effect of transwell insert on the induction of CCL2,CXCL8, and IL-6 release in co-culture of human eosinophils and epidermal keratinocytes upon IL-33 stimulation" --- p.110 / Chapter 4.3 --- Discussion --- p.113 / Chapter Chapter 5: --- Concluding Remarks and Future Perspectives --- p.120 / Chapter 5.1 --- Concluding Remarks --- p.120 / Chapter 5.2 --- Future Perspectives --- p.123 / Appendix --- p.126 / References --- p.127
|
332 |
Allergenicity evaluation of genetically engineered high-lysine GT3 rice.January 2010 (has links)
Yang, Fan. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 111-132). / Abstracts in English and Chinese. / ACKNOWLEDGEMENTS --- p.iii / ABSTRACT --- p.iv / TABLE OF CONTENTS --- p.viii / LIST OF FIGURES --- p.xii / LIST OF TABLES --- p.xv / LIST OF ABBREVIATIONS --- p.xvi / Chapter Chatper 1. --- General Introduction --- p.1 / Chapter Chapter 2. --- Literature Review --- p.5 / Chapter 2.1 --- Facts on food allergy --- p.5 / Chapter 2.1.1 --- Food allergy and its prevalence --- p.5 / Chapter 2.1.2 --- Pathogenesis of food allergy --- p.6 / Chapter 2.1.3 --- Clineal disorders caused and diagnosis of food allergy --- p.8 / Chapter 2.2 --- Allergenicity assessment of genetically engineered food --- p.13 / Chapter 2.2.1 --- The structural and sequence homology of proteins as a criterion for food allergenicity assessment --- p.14 / Chapter 2.2.2 --- Digestion stability as a criterion for food allergenicity assessment --- p.15 / Chapter 2.2.3 --- Animal models for Food Allergenicity Assessment --- p.21 / Chapter 2.3 --- The importance of rice and its nutritional facts --- p.27 / Chapter 2.3.1 --- The importance of rice --- p.27 / Chapter 2.3.2 --- Rice nutritional facts and its relationship with malnutrition --- p.28 / Chapter 2.4 --- Food allergenicity research in rice --- p.30 / Chapter 2.5 --- Glutelin overexpression transgenic rice GT3 --- p.33 / Chapter 2.6 --- Recent and future perspectives for treatment of food allergy --- p.36 / Chapter Chapter 3. --- Materials and Methods --- p.39 / Chapter 3.1 --- Rice Seed Protein Extraction --- p.39 / Chapter 3.1.1 --- Rice varieties for protein extraction --- p.39 / Chapter 3.1.2 --- Protein extraction from rice seeds --- p.39 / Chapter 3.1.3 --- Fractionation of major rice seed storage proteins --- p.40 / Chapter 3.1.4. --- Protein quantification --- p.41 / Chapter 3.1.5 --- Tricine SDS-PAGE --- p.42 / Chapter 3.2 --- Simulated Gastric Digestibility Assay --- p.43 / Chapter 3.2.1 --- Assay System --- p.43 / Chapter 3.2.2 --- Preparation of Simulated Gastric Fluid --- p.43 / Chapter 3.2.3 --- Assay Procedures --- p.44 / Chapter 3.2.4 --- Results Interpretation --- p.44 / Chapter 3.3 --- Construction of Mouse Models --- p.45 / Chapter 3.3.1 --- Mouse strain and reagents used --- p.45 / Chapter 3.3.2 --- Mouse Model I --- p.46 / Chapter 3.3.3 --- Mouse Model II --- p.50 / Chapter 3.3.4 --- Mouse Model III --- p.51 / Chapter 3.4 --- Bioinformatic Analysis of Glutelin Sequence --- p.52 / Chapter 3.5 --- Epitope Mapping of Glutelin --- p.55 / Chapter 3.5.1 --- Bioinformatic Analysis --- p.55 / Chapter 3.5.2 --- Direct and Competitive ELISA --- p.56 / Chapter 3.5.3 --- Western Blot Analysis --- p.57 / Chapter 3.5.4 --- IgE-binding assay --- p.58 / Chapter Chapter 4. --- Results and Discussion --- p.60 / Chapter 4.1 --- Rice Seed Protein Extraction --- p.60 / Chapter 4.1.1 --- Rice Protein Extraction --- p.60 / Chapter 4.1.2 --- Extraction of rice major seed storage protein fractions --- p.62 / Chapter 4.2 --- Simulated Gastric Digestibility Assay --- p.64 / Chapter 4.2.1 --- Pepsin Digestibility of total protein from GT3 and WT rice seeds --- p.64 / Chapter 4.2.2 --- Pepsin Digestibility of major storage protein fractions in GT3 and WT rice --- p.68 / Chapter 4.2.3 --- Summary of Pepsin Digestibility Assay --- p.74 / Chapter 4.3 --- Mouse Model I --- p.75 / Chapter 4.3.1 --- Protein-specific IgE levels --- p.75 / Chapter 4.3.2 --- Protein-specific IgG1 and IgG2a levels --- p.77 / Chapter 4.3.3 --- Allergic Response Test --- p.79 / Chapter 4.3.4 --- Summary from Mouse Model I --- p.81 / Chapter 4.4 --- Mouse Model II --- p.83 / Chapter 4.4.1 --- Proteins specific IgE levels --- p.84 / Chapter 4.4.2 --- Proteins specific IgG1 and IgG2a levels --- p.85 / Chapter 4.4.3 --- Allergic Response Test --- p.87 / Chapter 4.4.4 --- Summary from Mouse Model II --- p.88 / Chapter 4.5 --- Mouse Model III --- p.90 / Chapter 4.5.1 --- Protein-specific IgE levels --- p.90 / Chapter 4.5.2 --- Proteins specific IgG1 and IgG2a levels --- p.91 / Chapter 4.5.3 --- Allergic Response Test --- p.93 / Chapter 4.5.4 --- Summary from Mouse Model III --- p.93 / Chapter 4.6 --- Potential allergenicity of rice glutelin by bioinformatics and epitope mapping --- p.94 / Chapter 4.6.1 --- Bioinformatic analysis --- p.94 / Chapter 4.6.2 --- ELISA analysis of synthesized epitopes --- p.97 / Chapter 4.6.3 --- Western Blot Analysis --- p.99 / Chapter 4.6.4 --- IgE-binding assay --- p.103 / Chapter Chapter 5. --- Conclusion and Future Perspectives --- p.109 / References --- p.111
|
333 |
Intracellular regulatory mechanisms of the activation of human eosinophils by TSLP, IL-27 and ligands of NOD-like receptors in allergic inflammation. / CUHK electronic theses & dissertations collectionJanuary 2010 (has links)
Accumulating evidence has indicated that microbial infection could intensify allergic responses. Previous findings demonstrated that eosinophil activation could be elicited by bacterial and viral conserved molecular pattern through TLR. Recently, two cytoplasmic pattern recognition receptors, NLR protein NOD1 and NOD2, have been discovered and the important roles in innate immunity have been elucidated. Eosinophils alone have little responses upon the stimulation with ligands of NOD1 and NOD2. Since airway eosinophils increase in more numbers of asthmatic patients compared to control subjects, we investigated the co-culture system of eosinophils and human bronchial epithelial cells to illustrate the potential immunopathological roles of NOD1 and NOD2 in asthma processes. In the co-culture system, NOD1 ligand gamma-D-Glu-mDAP (iE-DAP) and NOD2 ligand muramyl dipeptide (MDP) could upregulate cell surface expression of CD1 8 and ICAM-1 on eosinophils and ICAM-1 and vascular cell adhesion molecule-1 (VCAM-1) on bronchial epithelial cells, as well as induce chemokines CCL2 and CXCL8 release. These findings therefore imply the direct interaction and activation between the two cells upon NOD1 and NOD2 ligand stimulation. / Allergic diseases are prevalent and their incidences have been increasing worldwide. Eosinophils are the principal effector cells for the late phase response in allergic inflammation. The infiltration of eosinophils together with other inflammatory cells at the local inflammatory sites is the major characteristic in allergic inflammation. However, the detailed innnunopathological responses and mechanisms of the activation of eosinophils in allergic inflammation are not well defined. In the present study, we investigated and attempted to elucidate the mechanisms of eosinophil activation induced by various stimuli, including thymic stromal lymphopoietin (TSLP), the novel interleukin (IL)-12 family cytokine IL-27, and ligands of nucleotide-binding oligomerization domain (NOD) like receptor (NLR) protein NOD1 and NOD2 upon interaction with bronchial epithelial cells. / In conclusion, the above findings demonstrated that eosinophils could be potently activated by diverse stimuli and regulated by multiple intracellular regulatory mechanisms. The elucidation of eosinophil activation may offer new therapeutic stategies and clues for the treatment of allergic diseases. / Recently, the novel IL-12 family member IL-27 was found to regulate immune responses, exerting either stimulation or suppression effects. We found that eosinophils constitutively expressed IL-27 receptor heterodimer, gp130 and WSX-1. IL-27 could prolong eosinophil survival by reducing apoptosis, modulate the expression of adhesion molecules to facilitate eosinophil adhesion and accumulation, and induce the release of proinflammatory cytokines IL-6, tumor necrosis factor (TNF)-aalpha IL-1beta and chemokines CCL2, CXCL8 and CXCL1. The stimulatory effects of IL-27 on eosinophils could not be abrogated by IL-25, hematopoietic cytokine granulocyte-macrophage colony stimulating factor (GM-CSF) and toll-like receptor (TLR) 4 ligand lipopolysaccharide (LPS). These findings were different from the effects of IL-27 and LPS on monocytes. Intracellular signaling mechanistic studies showed that IL-27-mediated eosinophil activation was differentially regulated by MAPKs and NF-kappaB. Based on the above results, IL-27 could play crucial roles in allergic diseases by the activation of eosinophils via differential intracellular signaling cascades. However, IL-27 has been shown to suppress allergic diseases in mouse models. According to our findings of its activating effects on human eosinophils, IL-27 may play pleiotropic roles in human allergic responses. / TSLP is a novel IL-7-like cytokine highly expressed by bronchial epithelial cells and skin keratinocytes in allergic diseases. TSLP acts as a master switch for allergic inflammation through the activation of dendritic cells and mast cells for initiating inflammatory Th2 responses. To elucidate the immunological cascades of epithelium/keatinocyte-eosinophil mediated allergic inflammation, we examined the modulating effects of TSLP on human eosinophils. We observed that human eosinophils constitutively expressed TSLP receptor complex comprising TSLP-binding chain TSLPR and IL-7Ralpha chain. TSLP could significantly delay eosinophil apoptosis, up-regulate the cell surface expression of adhesion molecule CD18 and intercellular adhesion molecule-1 (ICAM-1) but down-regulate L-selectin, enhance eosinophil adhesion to fibronectin, and induce the release of inflammatory cytokine 1L-6 and chemokines CXCL8, CXCL1 and CCL2. All these effects were concentration-dependent and TSLP-specific. TSLP regulated the above effects through the activation of extracellular signal-regulated protein kinase (ERK), p38 mitogen activated protein kinase (MAPK) and nuclear factor (NF)-kappaB signaling pathway, but not signal transducer and activator of transcription (STAT)-5 and STAT-3 which were usually activated in other effector cells upon TSLP stimulation. Collectively, the above findings elucidated the pro-allergic mechanisms of TSLP via the activation of distinct intracellular signaling pathways in eosinophils. / Hu, Shuiqing. / Adviser: Wong Chin Kwok. / Source: Dissertation Abstracts International, Volume: 72-04, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 176-216). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. Ann Arbor, MI : ProQuest Information and Learning Company, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.
|
334 |
Characterization of a mouse model of shrimp allergy.January 2007 (has links)
Lee, Yuen Shan. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2007. / Includes bibliographical references (leaves 81-102). / Abstracts in English and Chinese. / Abstract --- p.i / Acknowledgements --- p.iv / Table of contents --- p.vi / List of Figures --- p.ix / List of Abbreviations --- p.xi / Chapter Chapter 1. --- General introduction --- p.1 / Chapter Chapter 2. --- Literature review / Chapter 2.1 --- History of food allergy research --- p.3 / Chapter 2.2 --- Prevalence of food allergy --- p.4 / Chapter 2.3 --- Clinical symptoms of food allergy --- p.6 / Chapter 2.4 --- Mechanism of food allergy --- p.6 / Chapter 2.4.1 --- Properties of food allergens --- p.7 / Chapter 2.4.2 --- Exposures to food allergens in the gastrointestinal tract --- p.8 / Chapter 2.4.3 --- Oral tolerance and its relationship to food allergy --- p.9 / Chapter 2.4.4 --- Cellular mechanism of food allergy --- p.13 / Chapter 2.5 --- Studies on seafood allergies and allergens --- p.17 / Chapter 2.6 --- Use of animal models in the study of food allergy --- p.22 / Chapter 2.6.1 --- Selection of species and strain for developing animal models --- p.22 / Chapter 2.6.2 --- Parameters of sensitization protocol --- p.25 / Chapter 2.6.3 --- Lessons from animal models --- p.27 / Chapter 2.6.3.1 --- Investigations on pathogenesis of food allergy --- p.27 / Chapter 2.6.3.2 --- Studies on development of therapeutic strategies --- p.28 / Chapter Chapter 3. --- Characterization of hypersensitive responses to recombinant shrimp tropomyosin in mice / Chapter 3.1 --- Introduction --- p.30 / Chapter 3.2 --- Materials and Methods / Chapter 3.2.1 --- Preparation of the recombinant shrimp tropomyosin / Chapter 3.2.1.1 --- Expression of the recombinant shrimp tropomyosin --- p.32 / Chapter 3.2.1.2 --- Extraction and purification of the recombinant protein under native condition --- p.32 / Chapter 3.2.1.3 --- Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) --- p.33 / Chapter 3.2.1.4 --- Quantification of the recombinant protein and detection of level of endotoxin in the protein --- p.34 / Chapter 3.2.2 --- Characterization of hypersensitive responsesin mice / Chapter 3.2.2.1 --- Mice --- p.37 / Chapter 3.2.2.2 --- Sensitization and challenge of mice --- p.37 / Chapter 3.2.2.3 --- Assessment of systemic anaphylaxis responses --- p.38 / Chapter 3.2.2.4 --- Detection of shrimp tropomyosin specific IgE level --- p.39 / Chapter 3.2.2.5 --- Passive cutaneous anaphylaxis (PCA) test --- p.40 / Chapter 3.2.2.6 --- In vitro proliferation assay under stimulation of shrimp tropomyosin --- p.40 / Chapter 3.2.2.7 --- Cytokine profile of splenocytes --- p.42 / Chapter 3.2.2.8 --- Histological examination of small intestine --- p.44 / Chapter 3.2.2.9 --- Statistical analysis --- p.45 / Chapter 3.3 --- Results / Chapter 3.3.1 --- Preparation of the recombinant shrimp tropomyosin --- p.47 / Chapter 3.3.2 --- Induction of systemic anaphylaxis responses after challenge --- p.48 / Chapter 3.3.3 --- Elevated level of shrimp tropomyosin specific IgE --- p.49 / Chapter 3.3.4 --- Passive cutaneous anaphylaxis (PCA) reactions --- p.50 / Chapter 3.3.5 --- Proliferation response of splenocytes under in vitro stimulation --- p.54 / Chapter 3.3.6 --- Cytokine profiles of restimulated splenocytes --- p.58 / Chapter 3.3.7 --- Histology of small intestine --- p.65 / Chapter 3.4 --- Discussion --- p.68 / Chapter Chapter 4. --- General conclusion --- p.78 / References --- p.81
|
335 |
The Association of Cancer Development in Patients with Systemic Lupus ErythematosusColey, Rose Michelle 01 January 2016 (has links)
The Association of Cancer Development in Patients with Systemic Lupus Erythematosus by
Rose Michelle Coley
MPH, Walden University, 2011
BS, University of Mount Olive, 2008
Dissertation Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy
Public Health
Walden University
March 2016
Both cancer and autoimmune diseases have been associated with numerous factors that may independently lead to the development of either disease. When these factors overlap the difficulty in assessing association is compounded. The numerous factors that are thought to cause systemic lupus erythematosus (SLE), which leads to the development of cancer, makes the study of an association between the 2 diseases challenging. The purpose of this study was to examine whether the risk of cancer development increased in SLE patients compared to the risk in non-SLE patients. Researchers have not shown consistent relationships of cancer development in patients with SLE; however, consideration of the various factors that contribute to the diseases is necessary to measure an association between the 2 diseases. This study used the Clinical Practice Research database (CPRD), a large, population-based database to test the relationship between SLE and cancer. A matched retrospective cohort study among SLE (n=3025) and non-SLE (n=180555) patients was conducted using the propensity score methodology to help balance the differences between the comparison groups. The propensity score methodology created a similar distribution of observed baseline covariates between the 2 groups. With adjustment for age, the predictor variable of SLE indicates that a patient with SLE is still 2.7 times more likely to develop cancer than is a non-SLE patient. The study outcomes could promote positive social change by reinforcing current recommendations for cancer screenings in persons with SLE, which could enhance the ability to detect cancer early enough to decrease mortality because of cancer in persons with SLE.
|
336 |
Assessing Teachers' Confidence in Implementing Food Allergy Emergency PlansHawkins, Keturah Elizabeth 01 January 2017 (has links)
Food allergies are an increasing health concern in the United States, affecting nearly 6 million children under the age of 18 years. Research has suggested that 18% of school-age children will have their first allergic reactions at school. Life-threatening allergic reactions experienced by children in the school setting are on the rise; however, little is known about how schools implement policies and practices in response to this issue. The purpose of this quantitative cross-sectional study was to narrow the knowledge gap by examining teachers' knowledge, ability, and confidence level caring for students with food allergies. Bandura's social cognitive theory, which holds that education and experience influence confidence implementing tasks, served as the framework that guided this research. The electronic survey was distributed to a convenience sample of 300 elementary school teachers; 93 respondents completed it. Eighty completed surveys were used in the analysis. Multiple linear regression models were constructed to analyze the relationships among confidence, education, and training related to food allergies. Results showed that teachers who lacked knowledge of food allergies also lacked confidence implementing food allergy plans. School personnel responsible for planning or revising food allergy response protocols can use these findings. The potential for positive social change includes identifying training opportunities, developing policies to sustain food allergy knowledge, and building the capacity of all school staff to implement life-saving measures when children are experiencing allergic reactions.
|
337 |
Pilotstudie zur Allergieprävention in weiterführenden Schulen / Pilot study on allergy prevention at secondary schoolsWilbrand, Sebastian 30 October 2019 (has links)
No description available.
|
338 |
The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growthElkovich, Andrea J 01 January 2019 (has links)
Myeloid Derived Suppressor Cells (MDSC) represent a significant hurdle to cancer immunotherapy because they dampen anti-tumor cytotoxic T cell responses. Previous studies have reported on the myelo-depletive effects of certain chemotherapies. Using guadecitabine, a next-generation DNA methyltransferase inhibitor (DNMTi), we observed significantly reduced tumor burden in the 4T1 murine mammary carcinoma model. Guadecitabine treatment prevents excessive tumor-induced myeloid proliferation and systemic accumulation, and skews remaining MDSCs toward a beneficial antigen-presenting phenotype. Together, this alters the splenic environment to improve T cell activation and interferon-gamma (IFNg) production. Additionally, guadecitabine enhances the therapeutic effect of adoptively transferred antigen-experienced lymphocytes to diminish tumor growth and improve overall survival. Based on these findings, the immune-modulatory effects of guadecitabine can help rescue the anti-tumor immune response and could contribute to the overall effectiveness of current cancer immunotherapies.
Allergies and asthma are common ailments that are on the rise around the world. Mast cells play a direct role in the signs and symptoms characteristic in allergic patients. The family of A Disintegrin And Metalloproteinases (ADAMs) are involved in regulating many cellular processes by cleaving surface receptors, ligands, and signaling molecules. We sought to determine the role of ADAM17 in mast cell activity. In studies using ADAM17-deficient mast cells, percent degranulation and cytokines released by IgE-mediated activation were significantly reduced. Interestingly, ionomycin-activation was unchanged, suggesting ADAM17 may be involved in IgE-mediated mast cell activation upstream of calcium release. Additionally, ADAM17MC-/- mice showed protection from IgE-, but not histamine-, mediated passive systemic anaphylaxis (PSA). The underlying mechanism behind the reduced degranulation occurs through signaling deficiencies downstream of Lyn phosphorylation. Together, the data suggest that ADAM17 is required for proper mast cell signaling through its interaction with the Src family kinase, Lyn.
|
339 |
Pyly vybraných alergenních rostlin a jejich didaktické využití ve výuce biologie na gymnáziích / Pollens of Selected Alergenic Plants and Their Didactic Use in Teaching Biology at High SchoolsPýchová, Adéla January 2019 (has links)
7 Abstract The thesis is focused on the pollen of selected allergenic plants. Thesis is structured into two parts., pollination and fertilization , development of the pollen grain , its structure and chemical composition. The end of the theoretical part, dedicated to allergies, is divided into subsections dealing with First, teoretical part describes the flower and its morphology, discusses the pollen grain, stamen anatomical structure immunity and allergies, naming and registration of allergens and cross- pollen allergy . The practical part contains an analysis of curriculum for students of secondary schools. An integral part of the work is a survey of teachers in secondary schools, in which method of questioning was used. The aim of this questioning was to determine the presence of solved issue in terms of representation of pollen and pollen allergens in textbooks for secondary schools , as well as the inclusion of this issue in the official curriculum, under the National Programme for the Development of Education in the Czech Republic. Based on the results of a questionnaire survey of secondary school teachers, teaching materials have been developed in the form of two worksheets for teaching botany and guidance on laboratory exercises in plant biology.
|
340 |
Identification Of B And T Cell Epitopes Using Recombinant ProteinsJanuary 2014 (has links)
acase@tulane.edu
|
Page generated in 0.0413 seconds